{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:41:44Z","timestamp":1761514904308,"version":"3.37.3"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Coronavirus disease-2019 (COVID-19) causes acute respiratory distress syndrome. Patients with adrenal insufficiency (AI) may develop severe complications due to this infection and should undergo COVID-19 vaccination; however, there is no consensus about the management of their replacement therapy. The aim of our study was to evaluate the tolerability and need for glucocorticoid dose adjustment related to COVID-19 mRNA vaccines in a cohort of patients with AI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and methods<\/jats:title>\n                  <jats:p>We prospectively administered to 88 patients (51 M\/37 F; mean age: 62.3 \u00b1 16 years), with AI (28 primary and 60 secondary AI), a questionnaire about the occurrence, severity and duration of the side effects and the need for glucocorticoid dose adjustment within 1 week after the first and the second dose of COVID-19 mRNA vaccines (Pfizer\u2013BioNTech and Moderna).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Side effects of mild to moderate severity occurred in about 70% of patients after both vaccine doses. The most common adverse events were pain at the injection site, fatigue, fever and flu-like symptoms. The occurrence and severity of the side effects were not correlated to gender, type of AI and mRNA vaccine, but their total number was higher after the second vaccine dose. Doubling the oral glucocorticoid dose was needed in up to 8% of patients, especially after the second vaccine dose, but no parenteral administration was required.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>COVID-19 mRNA vaccines were well tolerated in patients with AI. Side effects were similar to those observed in the general population, and increasing glucocorticoid replacement therapy before vaccine administration was not needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1530\/eje-21-1236","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T16:07:46Z","timestamp":1654186066000},"page":"K7-K11","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":6,"title":["No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-6384","authenticated-orcid":false,"given":"Tania","family":"Pilli","sequence":"first","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Dalmiglio","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-2114","authenticated-orcid":false,"given":"Gilda","family":"Dalmazio","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-9027","authenticated-orcid":false,"given":"Alfonso","family":"Sagnella","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Forleo","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Brilli","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Maino","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ciuoli","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-1751","authenticated-orcid":false,"given":"Maria Grazia","family":"Castagna","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medical, Surgical and Neurological Sciences, University of Siena , Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2023010809165905100_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","journal-title":"Nature Microbiology"},{"key":"2023010809165905100_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"2023010809165905100_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"2023010809165905100_bib4","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"key":"2023010809165905100_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased infection risk in Addison's disease and congenital adrenal hyperplasia","volume":"105","author":"Tresoldi","year":"2020","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165905100_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-16-0969","article-title":"Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality","volume":"176","author":"Bancos","year":"2017","journal-title":"European Journal of Endocrinology"},{"key":"2023010809165905100_bib7","first-page":"173","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet: Diabetes and Endocrinology"},{"key":"2023010809165905100_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"2023010809165905100_bib9","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809165905100_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cen.12865","article-title":"Incidence of adrenal crisis in patients with adrenal insufficiency","volume":"84","author":"Smans","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2023010809165905100_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-16-0803","article-title":"Clinical features and practice patterns of treatment for adrenal crisis: a nationwide cross-sectional study in Japan","volume":"176","author":"Ono","year":"2017","journal-title":"European Journal of Endocrinology"},{"key":"2023010809165905100_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","article-title":"COVID-19 and endocrine diseases: a statement from the European Society of Endocrinology","volume":"68","author":"Puig-Domingo","year":"2020","journal-title":"Endocrine"},{"key":"2023010809165905100_bib13","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1530\/EJE-20-0386","article-title":"Endocrinology in the time of COVID-19","volume":"183","author":"Arlt","year":"2020","journal-title":"European Journal of Endocrinology"},{"key":"2023010809165905100_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eprac.2021.01.013","article-title":"COVID-19 vaccine","volume":"27","author":"Fernandes","year":"2021","journal-title":"Endocrine Practice"},{"key":"2023010809165905100_bib15","first-page":"1663","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"2023010809165905100_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11102-021-01130-x","article-title":"Glucocorticoid use in patient with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement","volume":"24","author":"Katznelson","year":"2021","journal-title":"Pituitary"},{"key":"2023010809165905100_bib17"},{"key":"2023010809165905100_bib18"},{"key":"2023010809165905100_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3803\/EnM.2021.404","article-title":"COVID-19 vaccination for endocrine patients: a position statement from the Korean Endocrine Society","volume":"36","author":"Ku","year":"2021","journal-title":"Endocrinology and Metabolism"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/1\/EJE-21-1236.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/1\/K7\/48516201\/eje-21-1236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/1\/K7\/48516201\/eje-21-1236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:17:44Z","timestamp":1676391464000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/1\/K7\/6972126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eje-21-1236","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"type":"print","value":"0804-4643"},{"type":"electronic","value":"1479-683X"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2022,6,1]]}}}